College of Biological and Pharmaceutical Engineering, West Anhui University, Lu'an, China.
Anhui Medical College, Hefei, China.
Cardiovasc Hematol Agents Med Chem. 2024;22(4):421-431. doi: 10.2174/1871525722666230907112509.
Natural medicine (NM) has been used since ancient times for therapeutic purposes worldwide. Presently, the combination of clopidogrel and NM with a reasonable synergistic effect has gained increasing acceptance in clinical therapeutics.
Here, we have performed a comprehensive retrieval of literature published in both English and Chinese databases until August 1, 2022, studying the synergistic interactions of clopidogrel and NM through pharmacokinetic/pharmacodynamic (PK-PD) analyses. We retrieved 7, 3, and 5 studies on PK analysis and 3, 3, and 8 studies on PD analysis for the interaction of clopidogrel with single herbal medicines, bioactive compounds, and herbal prescriptions, respectively. Most studies on NM have been found to mainly focus on preclinical observations, and there have been fewer clinical PK analyses.
A potential drug-herb interaction has been observed to occur when clopidogrel and NM were metabolized by an enzyme network comprising P-gp, CES1, and CYP450. In contrast, most PD studies have focused on clinical observations, and few preclinical findings have been reported. Some cases have suggested that the combination of the two types of drugs would alter the antiplatelet efficacy and adverse effects. Studies on PK, however, have shown significant or slightly varying results for the drug prototype and its metabolites.
In the combination therapies, the interaction between clopidogrel and NM was found to alter antiplatelet aggregation pathways and P2Y12 receptor function.
天然药物(NM)自古以来就在世界各地被用于治疗目的。目前,氯吡格雷与 NM 的联合应用具有合理的协同作用,在临床治疗中越来越受到认可。
我们全面检索了截至 2022 年 8 月 1 日发表在英文和中文数据库中的文献,通过药代动力学/药效学(PK-PD)分析研究氯吡格雷与 NM 的协同相互作用。我们检索了 7 项、3 项和 5 项关于 PK 分析的研究,以及 3 项、3 项和 8 项关于 PD 分析的研究,分别用于研究氯吡格雷与单味草药、生物活性化合物和草药方剂的相互作用。NM 的大多数研究主要集中在临床前观察,临床 PK 分析较少。
当氯吡格雷和 NM 被包含 P-gp、CES1 和 CYP450 的酶网络代谢时,观察到一种潜在的药物-草药相互作用。相比之下,大多数 PD 研究都集中在临床观察上,很少有临床前发现。有一些案例表明,这两种药物的联合使用会改变抗血小板疗效和不良反应。然而,PK 研究表明,对于原型药物及其代谢物,结果存在显著或略有不同。
在联合治疗中,发现氯吡格雷与 NM 的相互作用改变了抗血小板聚集途径和 P2Y12 受体功能。